Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
Conditions: Schizophrenia; Psychotic DisordersInterventions: Drug: Aripiprazole; Drug: Quetiapine; Drug: Ziprasidone; Behavioral: Cognitive batterySponsors: Fundación Marques de Valdecilla; Centro de Investigación Biomédica en Red de Salud Mental; Fundación Instituto de Investigación Marqués de Valdecilla, IDIVALCompleted - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2015 Category: Research Source Type: clinical trials